Results 31 to 40 of about 110,537 (308)

Health technology assessment of pathogen reduction technologies applied to plasma for clinical use [PDF]

, 2016
Although existing clinical evidence shows that the transfusion of blood components is becoming increasingly safe, the risk of transmission of known and unknown pathogens, new pathogens or re-emerging pathogens still persists.
Berrino, Alexandra, Casini, Marina, Cicchetti, Americo, Codella, Paola, Facco, Giuseppina, Fiore, Alessandra, Grazzini, Giuliano, Liumbruno, Giancarlo M., Marano, Giuseppe, Marchetti, Marco, Midolo, Emanuela, Minacori, Roberta, Refolo, Pietro, Romano, Federica, Ruggeri, Matteo, Sacchini, Dario, Spagnolo, Antonio G., Urbina, Irene, Vaglio, Stefania   +18 more
core   +1 more source

Gene frequency and distribution of human platelet antigen-1 to −6, −10, −15, and −21 of platelets donors in Wuhan, China

Global Medical Genetics
Background: In this study, the frequency of human platelet antigen (HPA) alleles and genotypes of platelet donors in Wuhan was evaluated and differences in HPA distribution between Wuhan and other regions in China were compared. Study Design and Methods:
Zhen Qu, Wangxia Li, Yuanyan Zhu, Xue Zheng, Mingdi He, Gang Shen, Anyu Bao   +6 more
doaj   +1 more source

The present situation and advance of red blood cell transfusion triggers

Zhongguo shuxue zazhi
In clinical practice, red blood cell infusion needs to be based on the patient′s hemoglobin level. However, different guidelines recommend different thresholds for red blood cell infusion and the timing of blood transfusion initiation is still ...
Yuye CHEN, Hong LYU, Qian LI, Jingjia SHEN, Jia SHI   +4 more
doaj   +1 more source

Preventing blood transfusion failures: FMEA, an effective assessment method

BMC Health Services Research, 2017
Background Failure Mode and Effect Analysis (FMEA) is a method used to assess the risk of failures and harms to patients during the medical process and to identify the associated clinical issues.
Zhila Najafpour, Mojtaba Hasoumi, Faranak Behzadi, Efat Mohamadi, Mohamadreza Jafary, Morteza Saeedi   +5 more
doaj   +1 more source

Transfusion management of patients with alloanti-Gerbich antibodies: Case report [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2011
Introduction. Transfusion management of patients who are alloimmunized against high-prevalence erythrocyte antigens is often problematic. Strategy management depends, not only on the specific clinical circumstances of the patient, but also on the ...
Jovanović Radmila, Bujandrić Nevenka, Lisulov Slobodanka, Bogdanović Sanja   +3 more
doaj   +1 more source

Isohemagglutinins of Graft Origin after ABO-Unmatched Liver Transplantation [PDF]

, 1984
THE increasing success of liver transplantation in recent years has provided an experimental model to study and document the hepatic synthesis of many plasma proteins.12345 The normal hepatobiliary tract has not been regarded as a major source of ...
Anderson, Bird, Borel, Glenn Ramsey, Gwenn D. Lindsay, Jacob Nusbacher, Kukral, Lindsey, Lundgren, Marchioro, Rannie, Shaw, Starzl, Thomas E. Starzl   +13 more
core   +1 more source

Pulmonary Complications of Transfused Blood Components [PDF]

Critical Care Nursing Clinics of North America, 2012
Three transfusion complications are responsible for the majority of the morbidity and mortality in hospitalized patients. This article discusses the respiratory complications associated with these pathophysiologic processes, including definitions, diagnosis, mechanism, incidence, risk factors, clinical management, and strategies for prevention. It also
openaire   +2 more sources

Transfusion support in the first 100 days of allogeneic, matched, related hematopoietic stem cell transplant

Indian Journal of Transplantation, 2023
Background: Patients receiving hematopoietic stem-cell transplantation (HSCT) require extensive transfusion support until red blood cell (RBC) and platelet engraftment occurs.
Prashant Pandey, Divya Setya, Esha Kaul, Shweta Ranjan, Supriya Kumari   +4 more
doaj   +1 more source

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi, Daisuke Katagiri, Takeyuki Watadani, Shunichi Matsuda, Hiroshi Kaneko, Noritoshi Arai   +5 more
wiley   +1 more source

Underreporting of transfusion incidents

Hematology, Transfusion and Cell Therapy
Background: Blood transfusion is an effective therapeutic practice. However, even adopting all procedures for transfusion safety, there are risks, one of which is immediate adverse reactions.
Josiane Garcia, Anna Cecília Dias Maciel Carneiro, Sheila Soares Silva, Karla Fabiana Nunes da Silva, Joilson Meneguci, Helio Moraes-Souza   +5 more
doaj   +1 more source